MDEA

Medical Design Excellence Awards (MDEAs) Announce Winners and Finalists for the 2022 Competition

Retrieved on: 
Friday, April 8, 2022

The Medical Design Excellence Awards (MDEAs), the medtech industrys premier awards program, organized by Informa Markets Engineering, publisher of Medical Device and Diagnostic Industry (MD+DI), today announced the winners and finalists for the 2022 MDEA competition.

Key Points: 
  • The Medical Design Excellence Awards (MDEAs), the medtech industrys premier awards program, organized by Informa Markets Engineering, publisher of Medical Device and Diagnostic Industry (MD+DI), today announced the winners and finalists for the 2022 MDEA competition.
  • Spanning ten product categories, the annual competition recognizes products that are moving the $450 billion medical device industry forward through life-saving innovations and remarkable technological advancements.
  • Since its inception in 1998, the MDEA program has honored significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.
  • Congratulations to our winners and finalists who are shaping much-needed progress in a meaningful and impactful way.

Seno Medical’s Imagio® Breast Imaging System Named Finalist for Medical Device Excellence Awards

Retrieved on: 
Tuesday, March 29, 2022

San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medicals Imagio Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.

Key Points: 
  • San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medicals Imagio Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.
  • The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry.
  • Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging.
  • Approved by the US FDA in January 2021, Seno Medicals Imagio Breast Imaging System fuses opto-acoustic technology with ultrasound (OA/US) to generate real-time functional and anatomical images of the breast.

Seno Medical’s Imagio® Breast Imaging System Named Finalist for Medical Device Excellence Awards

Retrieved on: 
Tuesday, March 29, 2022

San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medicals Imagio Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.

Key Points: 
  • San Antonio, Texas, March 29, 2022 (GLOBE NEWSWIRE) -- Seno Medicals Imagio Breast Imaging System has been named a finalist in the 2022 Medical Device Excellence Awards, in the Radiological, Imaging, and Electromechanical Devices category.
  • The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry.
  • Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging.
  • Approved by the US FDA in January 2021, Seno Medicals Imagio Breast Imaging System fuses opto-acoustic technology with ultrasound (OA/US) to generate real-time functional and anatomical images of the breast.

binx health Voted as Finalist in Medical Design Excellence Awards 2022

Retrieved on: 
Wednesday, March 30, 2022

binx health , a healthcare technology and diagnostics company is pleased to announce its selection as a finalist in the Medical Design Excellence Awards 2022 .

Key Points: 
  • binx health , a healthcare technology and diagnostics company is pleased to announce its selection as a finalist in the Medical Design Excellence Awards 2022 .
  • The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry with a mission to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.
  • We are honored to be included in the esteemed list of MDEA 2022 finalists, said Anna Dixon, CTO of binx health.
  • binx healths io was selected as a finalist in the "Testing and Diagnostic Products and Systems" category.

Suture Ease Showcases Two New Product Offerings at SAGES 2022

Retrieved on: 
Tuesday, March 15, 2022

The product performs the same way as the fully disposable EzStitch System, yet is configured with a disposable guide and a reusable suture passer.

Key Points: 
  • The product performs the same way as the fully disposable EzStitch System, yet is configured with a disposable guide and a reusable suture passer.
  • The Suture Ease system is equipped with a conventional cone guide coupled with a premium Securus EP suture passer.
  • Based in San Jose, California, Suture Ease develops and markets award-winning innovative technologies that combine efficacy and ease of use to enhance laparoscopic procedures.
  • Suture Ease addresses this market need through its laparoscopic closure technologies, which facilitates easy, safe and reliable fascial closure.

National Quality Initiatives Amplify Health Systems’ Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position

Retrieved on: 
Tuesday, March 15, 2022

As organizations place a growing emphasis on patient safety and payments shift to a more value-based model, hospitals and health systems are steadily increasing their focus on ensuring efficient glycemic management.

Key Points: 
  • As organizations place a growing emphasis on patient safety and payments shift to a more value-based model, hospitals and health systems are steadily increasing their focus on ensuring efficient glycemic management.
  • The CMS national quality initiatives have indicated that poor glycemic management has become too pervasive to ignore and hospitals must evolve.
  • Visit Booth #4135 to learn more about Glytec and the impact that insulin management software can have on health systems.
  • Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care.

MD&M East Announces 2021 Keynote and Speaker Lineup Set to Deliver Technical and Forward-looking Insights Impacting Medical Device Manufacturers

Retrieved on: 
Thursday, November 4, 2021

Despite an expected decline in 2020, the global medical device market is forecasted to surpass its current value and reach $603.5 billion in 2023 .

Key Points: 
  • Despite an expected decline in 2020, the global medical device market is forecasted to surpass its current value and reach $603.5 billion in 2023 .
  • This rapid growth presents immense opportunities as well as challenges for device manufacturers, requiring a steady pulse on the latest industry happenings and industry-wide agility to adapt to new technologies.
  • As such, we're thrilled to announce our keynote and speaker lineup for this year's edition that will facilitate conversation and ultimately, ideate solutions to today's challenges."
  • Join the MedExecWomen panel of experts as they discuss the keys to driving adoption of SaMD and digital solutions into medical practice.

Global Methyl Diethanolamine (MDEA) Global Market to 2025 - by Manufacturers, Regions, Technology and Application

Retrieved on: 
Friday, December 18, 2020

16.1.4 Huntsman Methyl Diethanolamine (Mdea) Sales, Revenue, Price and Gross Margin (2015-2020)

Key Points: 

16.1.4 Huntsman Methyl Diethanolamine (Mdea) Sales, Revenue, Price and Gross Margin (2015-2020)

Worldwide Industry for Methyl Diethanolamine to 2025 - Players Include Huntsman, BASF and Maoming Yunlong - ResearchAndMarkets.com

Retrieved on: 
Friday, December 11, 2020

This report describes the global market size of Methyl Diethanolamine (MDEA) from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025.

Key Points: 
  • This report describes the global market size of Methyl Diethanolamine (MDEA) from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025.
  • For the geography segment, regional supply, demand, major players, price is presented from 2015 to 2025.
  • The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
  • For the competitor segment, the report includes global key players of Methyl Diethanolamine (MDEA) as well as some small players.

Global N-MDEA Market to 2027 - Trends, Drivers, Restraints & Challenges - ResearchAndMarkets.com

Retrieved on: 
Friday, April 3, 2020

The "N-MDEA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "N-MDEA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The latest study collated and published analyzes the historical and present-day scenario of the global N-MDEA market to accurately gauge its potential future development.
  • The report also provides insightful information about how the N-MDEA market will progress during the forecast period of 2019 to 2027.
  • What are the winning imperatives of market frontrunners in the N-MDEA market?